To the full analysis
Argan stock: growth
ARG.PAArgan reported $278.8M in revenue for fiscal 2025, up 5.3% on the prior year, up 8% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
14.2%
per year from 2009 to 2025, per share 7.8%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
16.3%
per year from 2009 to 2025, per share 9.8%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2009 | |
|---|---|---|---|
| Revenue | 8.0% | 14.1% | 14.2% |
| Revenue per share | 5.1% | 7.5% | 7.8% |
| Earnings | −2.5% | 17.3% | no data |
| Earnings per share | −5.0% | 10.7% | no data |
| Free cash flow | no data | 29.8% | 16.3% |
| Free cash flow per share | no data | 22.3% | 9.8% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2009 | $33.49M | −$29.5M | $18.64M |
| 2010 | $41.91M | $44.75M | $27.14M |
| 2011 | $48.22M | $21.89M | −$19.81M |
| 2012 | $57.58M | $28.85M | −$25.91M |
| 2013 | $68.62M | $31.36M | $33.37M |
| 2014 | $73.39M | $45.22M | $18.87M |
| 2015 | $74.72M | $55.08M | $15.33M |
| 2016 | $74.35M | $105.55M | −$71M |
| 2017 | $83.82M | $101.59M | −$87.32M |
| 2018 | $94.62M | $160.15M | −$121.28M |
| 2019 | $113.12M | $238.28M | −$112.71M |
| 2020 | $189.53M | $309.01M | −$167.39M |
| 2021 | $205.74M | $740.34M | $53.41M |
| 2022 | $219.32M | $105.37M | $150.44M |
| 2023 | $244.64M | −$291.93M | $206.27M |
| 2024 | $264.81M | $272.26M | $192.28M |
| 2025 | $278.8M | $271.7M | $207.78M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 2 May 2025)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.